EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Inhibitory Immune Checkpoints beyond Programmed Cell Death Ligand 1 in Merkel Cell Carcinoma: Abundant Expression of TIGIT Independent of the Presence of Merkel Cell Polyoma Virus

Ferdinand Toberer, Julia K Winkler, Leroy Atienza Fernandez, Lea Adams, Alexander Brobeil, Marcell Tóth, Alexander H Enk, Jürgen C Becker, Anke Lonsdorf

Acta Dermato-Venereologica · 01.07.2025 · 105 · adv42882

DOI: 10.2340/actadv.v105.42882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Dermato-Venereologica, online erschienen am 01.07.2025. Verfasst von Ferdinand Toberer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Receptors, Immunologic, Skin Neoplasms, Merkel cell polyomavirus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Merkel cell carcinoma is a rare, aggressive skin cancer in which Merkel cell polyoma virus (MCPyV) is frequently pathogenically involved. After failure of anti-programmed cell death protein 1/programmed cell death ligand 1 immunotherapy, therapeutic options for advanced disease are limited. The contribution of the coinhibitory checkpoint molecule T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (TIGIT), a regulator of exhausted CD8+ T cells, to the immunosuppressive Merkel cell carcinoma microenvironment is understudied. This study evaluated the immunohistochemical expression of tumour (Tumor Proportion Score, TPS) and infiltrating immune cells (Immune Cell Score, ICS) for programmed cell death ligand 1, TIGIT, its high-affinity receptor CD155, and CD8 in 21 primary Merkel cell carcinoma and 6 metastases. Unlike CD155, TIGIT was abundantly expressed by tumour and immune cells and independent of the MCPyV status, determined by RT-PCR. Programmed cell death ligand 1+ immune cells were significantly increased in TIGIT TPS-positive and MCPyV-positive primary MCC along with significant intercorrelations of programmed cell death ligand 1 and TIGIT immune cell expression and CD8+ infiltrates. Programmed cell death ligand 1 IC-positivity correlated with superior disease-specific survival. The data indicate that TIGIT may contribute to local immune dysfunction in Merkel cell carcinoma, beyond programmed cell death ligand 1 and independent of MCPyV, and provide a rationale to further explore TIGIT as a potential target for Merkel cell carcinoma immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Merkel CellReceptors, ImmunologicSkin NeoplasmsMerkel cell polyomavirusB7-H1 AntigenPolyomavirus InfectionsTumor Virus InfectionsBiomarkers, TumorHumansMaleFemaleAgedMiddle AgedAged, 80 and overTumor MicroenvironmentLymphocytes, Tumor-InfiltratingCD8-Positive T-LymphocytesReceptors, Virus

Substanzen

TIGIT protein, humanReceptors, ImmunologicB7-H1 AntigenCD274 protein, humanpoliovirus receptorBiomarkers, TumorReceptors, Virus

Autor:innen und Institutionen

  • Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Departments of Translational Skin Cancer Research and Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf and German Cancer Research Center (DKFZ), Heid…
  • Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, Heidelberg, Germany.
  • Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany; Tissue Bank of the National Center for Tumor Diseases, Heidelberg, Germany.
  • Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany. anke.lonsdorf@med.uni-heidelberg.de.

Zitieren

APA

Toberer, F., Winkler, J. K., Atienza Fernandez, L., Adams, L., Brobeil, A., Tóth, M., Enk, A. H., Becker, J. C., & Lonsdorf, A. (2025). Inhibitory Immune Checkpoints beyond Programmed Cell Death Ligand 1 in Merkel Cell Carcinoma: Abundant Expression of TIGIT Independent of the Presence of Merkel Cell Polyoma Virus. Acta Dermato-Venereologica, 105, adv42882. https://doi.org/10.2340/actadv.v105.42882

Vancouver

Toberer F, Winkler JK, Atienza Fernandez L, Adams L, Brobeil A, Tóth M, et al. Inhibitory Immune Checkpoints beyond Programmed Cell Death Ligand 1 in Merkel Cell Carcinoma: Abundant Expression of TIGIT Independent of the Presence of Merkel Cell Polyoma Virus. Acta Dermato-Venereologica. 2025;105:adv42882. doi:10.2340/actadv.v105.42882

BibTeX
@article{Toberer2025,
  author = {Toberer, Ferdinand and Winkler, Julia K and Atienza Fernandez, Leroy and Adams, Lea and Brobeil, Alexander and Tóth, Marcell and Enk, Alexander H and Becker, Jürgen C and Lonsdorf, Anke},
  title = {Inhibitory Immune Checkpoints beyond Programmed Cell Death Ligand 1 in Merkel Cell Carcinoma: Abundant Expression of TIGIT Independent of the Presence of Merkel Cell Polyoma Virus},
  journal = {Acta Dermato-Venereologica},
  year = {2025},
  volume = {105},
  pages = {adv42882},
  doi = {10.2340/actadv.v105.42882}
}
Kostenlos starten →